Results 121 to 130 of about 600 (148)
Some of the next articles are maybe not open access.

CAN SINCALIDE CHOLESCINTIGRAPHY FULFIL THE ROLE OF A GALL‐BLADDER STRESS TEST FOR PATIENTS WITH GALL‐BLADDER STONES?

ANZ Journal of Surgery, 1998
Background:Patients referred to general surgeons for the treatment of gall‐bladder stones were studied to evaluate the role of sincalide cholescintigraphy as a gall‐bladder stress test in an effort to identify a group of patients whose pain was non‐biliary in origin and who would not be improved by cholecystectomy.Methods:Ten asymptomatic controls and ...
Jon Gani
exaly   +3 more sources

Comparison of intravenous and intramuscular sincalide (C-terminal octapeptide of cholecystokinin) on gallbladder contraction in man

Digestive Diseases and Sciences, 1981
The effects of intramuscular and intravenous sincalide on gallbladder contraction and visualization of the bile ducts were compared in a group of 37 subjects referred for oral cholecystography. The maximum reduction in gallbladder size observed after sincalide 400 ng/kg intramuscular, 54.7 +/- 7.2% (mean +/- SEM), occurred 25 min after injection and ...
Donald E Wilson
exaly   +3 more sources

Chemical Stability of Reconstituted Sincalide in Sterile Water Under 2 Different Storage Conditions [PDF]

open access: yesJournal of Nuclear Medicine Technology, 2020
This study aimed to evaluate the chemical stability of sincalide at 2 common storage conditions-room temperature and refrigeration-in an attempt to simulate the conditions faced during centralized reconstitution and subsequent distribution to regional clinical facilities.
Eric, Belanger   +4 more
exaly   +3 more sources

Kinevac (Sincalide for Injection)/Squibb Diagnostics

Gastroenterology Nursing, 1991
Sincalide is a rapid-acting, synthetic analog of cholecystokinin for intravenous use in postevacuation cholecystography. Serious reactions to sincalide have not been reported. The intravenous administration of sincalide causes a prompt contraction of the gallbladder as compared to the stimulus of a fatty meal which causes progressive contraction that ...
openaire   +2 more sources

Sincalide Cholescintigraphy—32 Years Later: Evidence-Based Data on Its Clinical Utility and Infusion Methodology

Seminars in Nuclear Medicine, 2012
Sincalide cholescintigraphy was first reported to have clinical utility in 1980. Since then, many publications have found that a reduced gallbladder ejection fraction (GBEF) can confirm the clinical diagnosis of acalculous chronic gallbladder disease and predict symptomatic relief with cholecystectomy.
Harvey A Ziessman
exaly   +3 more sources

Utilizing the Cholecystagogue, Ensure Plus, Results in Similar Hepatobiliary Scintigraphy Study Results and Patient Outcomes Status Post Cholecystectomy, in Comparison With Sincalide

Clinical Nuclear Medicine, 2020
Objective To determine if use of the oral cholecystagogue, Ensure Plus (EP), in hepatobiliary scintigraphy (HBS) leads to a similar distribution of normal and abnormal gallbladder ejection fractions (GBEFs) versus other historical secondary findings of chronic biliary disease in a similar patient population compared with the ...
Justin G Peacock, Kevin P Banks
exaly   +3 more sources

Practical Hepatobiliary Imaging Using Pretreatment with Sincalide in 139 Hepatobiliary Studies

Clinical Nuclear Medicine, 1985
Hepatobiliary studies were performed over a three-year period on 139 patients suspected of having cystic duct obstruction. Each patient was infused intravenously with sincalide, a C-terminal octapeptide of CCK, 15 minutes prior to the administration of the hepatobiliary imaging agent Tc-99m paraisopropyl iminodiacetic acid (PIPIDA).
F K, Patterson, J W, Kam
openaire   +2 more sources

Hemobilia Presenting as Intermittent Gastrointestinal Hemorrhage With Sincalide Confirmation A Case Report

Clinical Nuclear Medicine, 1995
An 82-year-old man had his third episode of melanotic stool. Two previous workups had failed to localize the source of bleeding. A Tc-99m labeled RBC scan visualized the gallbladder early in the study. Administration of sincalide visually decreased the activity, confirming gallbladder activity.
M E, Spieth   +5 more
openaire   +2 more sources

Artificial Intelligence in Sincalide-Stimulated Cholescintigraphy: A Pilot Study

Clinical Nuclear Medicine
Purpose: Sincalide-stimulated cholescintigraphy (SSC) calculates the gallbladder ejection fraction (GBEF) to diagnose functional gallbladder disorder. Currently, artificial intelligence (AI)-driven workflows that integrate real-time image processing and organ function calculation remain unexplored in nuclear medicine practice ...
Nghi C. Nguyen   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy